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Summary 
Multiple cell adhesion proteinsare up-regulated in vas- 
cular endothelial cells in response to TNFa and other 
inflammatory cytokines. This increase in cell adhesion 
gene expression is thought to require the transcription 
factor NF-KS. Here, we show that peptide aldehyde 
inhibitors of the proteasome, a multicatalytic protease 
recently shown to be required for the activation of NF- 
KB, block TNFa induction of the leukocyte adhesion 
molecules E-selectin, VCAM-1, and ICAM-1. Striking 
functional consequences of this inhibition were ob- 
served in analyses of leukocyte-endothelial interac- 
tions under defined flow conditions. Lymphocyte at- 
tachment to TNFa-treated endothelial monolayer’s was 
totally blocked, while neutrophil attachment was par- 
tially reduced but transmigration was essentially pre- 
vented. 
Introduction 
The emigration of leukocytes from the bloodstream to ex- 
travascular sites involves a series of adhesive interactions 
with activated endothelium (reviewed by Springer, 1994; 
Carlos and Harlan, 1994). Initial random contact is fol- 
lowed by rolling of the leukocytes along the vessel wall. 
The selectin family of adhesion proteins and lectin count- 
erreceptors mediate these initial adhesion events. In re- 
sponse to chemotactic factors and cytokines released in 
the local environment, leukocyte integrins are activated 
for subsequent interactions with endothelial ligands from 
the immunoglobulin gene superfamily. Leukocytes then 
flatten and spread on the endothelium in a process of ad- 
hesion strengthening. Tightly bound leukocytes then mi- 
grate to intercellular junctions, and diapedese between 
endothelial cells to enter the extravascular space and mi- 
grate to the areaof the inflammatory or immune response. 
The definition of the molecules involved in these adhesive 
interactions has led to a working model for the molecular 
basis of leukocyte-endothelial interactions, and provided 
insights into therapeutic approaches to regulate the 
flammatory response. 
Some of the adhesive proteins share a common regu 
tory feature in that endothelial expression is dramatica 
increased at sites of leukocyte recruitment. Endothelii 
leukocyte adhesion molecule-l (E-selectin, ELAM-1, 
CD82E) is expressed in capillary and venular endothelii 
at sites of acute and chronic inflammatory responses (I 
viewed by Pober and Cotran, 1990) and is rapidly induc 
by the tumor necrosis factor a (TNFa) and interleukir 
(IL-l) of the inflammatory cytokine, and bacterial lipopo 
saccharide (LPS) (Bevilacqua et al., 1989). The rise 
selectin expression may mediate the initial attachmc 
and rolling of neutrophils (Lawrence and Springer, 19s 
1993; Abbassi et al., 1993). All selectins recognize sialat 
carbohydrate determinants on their counterreceptors ( 
viewed by Lasky, 1992; Rosen, 1993). Vascular cell adt 
sion molecule-l (VCAM-1, CD108), an immunoglobul 
like molecule, is expressed by a variety of vascular 
well as nonvascular cells. In endothelial cells, VCAk 
expression is induced by the inflammatory cytokin 
somewhat more slowly than E-selectin (Osborn et i 
1989). Endothelial expression of VCAM-1 mediates 1 
recruitment of lymphocytes, monocytes, and eosinopt 
bearing a401 (VLA4, CD49d/CD29) or a4/37 integrl 
(Elites et al., 1990; Chan et al., 1992) in chronic inflamn 
tory and immune responses (Cybulsky and Gimbrol 
1991; Briscoe et al., 1991; Freedman et al., 1990). lnterc 
lular adhesion molecule-l (ICAM-1, CD54), also immul 
globulin-like, interacts with leukocyte 02 integrins (CD1 
CD18 and CD1 1 b/CD18), and is important for transenc 
thelial migration (Staunton et al., 1988; Smith et al., 198 
Basal levels of ICAM- are present on unstimulated enc 
thelial cells, but ICAM- also undergoes dramatic I 
regulation in response to inflammatory cytokines (WC 
heimer et al., 1992). 
Cytokine induction of E-selectin, VCAM-1 and ICAl 
genes leads to accumulation of high levels of mRNP 
endothelial cells (Bevilacqua et al., 1989; Osborn et 
1989; Staunton et al., 1988). Previous studies have dc 
onstrated that the increase in these mRNAs after induct 
is due to an increase in the rate of gene transcript 
(Whelan et al., 1991; Neish et al., 1992; Wertheimel 
al., 1992). To understand the mechanisms regulating 
cytokine-induced expression of these molecules, the 
man genes for E-selectin (Collins et al., 1991), VCAI 
(Cybulsky et al., 1991), and ICAM- (Degitz et al., 19 
Voraberger et al., 1991) have been cloned and the 1 
moter regions characterized. Cytokine responsivenes: 
the E-selectin promoter requires multiple elements: th 
NF-KB binding motifs, a single ATF-2 binding site, i 
multiple sites recognized by the high mobility group f 
tein, HMGI(Y) (Whitley et al., 1994; Lewis et al., 19 
Schindler and Baichwal, 1994). The organization of 1 
cytokine-inducible promoter is remarkably similar to 
virus-inducible promoter of the human interferon-l3 g( 
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(Whitley et al., 1994). The VCAM-1 promoter contains two 
NF-KB sites, which are required for cytokine-induced tran- 
scriptional activation (Neish et al., 1992; lademarco et al., 
1992) as well as an interferon regulatory factor-l (IRF-1) 
site, which cooperates with NF-KB to yield maximal cyto- 
kine responsiveness (Neish et al., 1995). Studies with the 
ICAM- promoter revealed that cytokine induction re- 
quires binding sites interacting with NF-KB and C/EBP 
(van de Stolpe et al.,1994; Hou et al., 1994). NF-KB may 
not only be required for these genes to respond to cyto- 
kine, but may also influence the temporal pattern of adhe- 
sive properties of endothelium during inflammatory re- 
sponses. 
NF-KB is a ubiquitous transcription factor and pleiotropic 
regulator of many genes involved in immune and inflam- 
matory responses (reviewed by Grilli et al., 1993; Thanos 
and Maniatis, 1995). This family of dimeric transcription 
factor complexes consists of ~50 (NF-kBl), and p52 (NF- 
kB2), which are both generated by proteolytic processing 
of precursor molecules, ~105 and ~100. The other mem- 
bersof this family, p65(RelA), c-Rel, and RelB, have potent 
transactivation domains. p5O/p65 is the predominant spe- 
cies found in endothelial cells, and binds to the NF-KB 
sites in both E-selectin and VCAM-1 (Read et al., 1994; 
Whitleyet al., 1994; Neish et al., 1995). NF-KB isactivated 
by posttranslational events involving phosphorylation and 
subsequent degradation of a cytoplasmic inhibitor, lkBa, 
which in resting cells prevents nuclear localization of NF- 
KB (reviewed by Beg and Baldwin, 1993). These factors 
interact in an autoregulatory mechanism: NF-KB mediates 
activation of the tkBa gene, resulting in replenishment of 
thecytoplasmic poolof itsown inhibitor(Brownet al., 1993; 
Sun et al., 1993; Scott et al., 1993; de Martin et al., 1993). 
The proteasome pathway has been linked to NF-KB acti- 
vation. The proteasome is a 26s complex localized in the 
cytoplasm and nucleus, and contains a 20s proteolytic 
core (reviewed by Goldberg and Rock, 1992; Peters, 1994; 
Ciechanover, 1994). This nonlysosomal pathway of pro- 
tein degradation is responsible for the turnover of abnor- 
mal and biologically active proteins in intact cells (re- 
viewed by Ciechanover, 1994). Reagents that inhibit the 
proteasomal pathway have recently been used to demon- 
strate that the proteasome is required for processing and 
presentation of major histocompatibility complex (MHC) 
class I antigens (Rock et al., 1994). Processing of the ~105 
NF-KB precursor into the active ~50 subunit also involves 
the proteasome proteolytic pathway. Inhibitors of the pro- 
teasome blocked lKBa degradation, and activation of NF- 
KB in response to TNFa in MG-63 and HeLa cells (Palom- 
bella et al., 1994). In endothelial cells, activation of NF-KB 
in response to TNFa occurs in parallel with degradation 
of IKBa (Read et al., 1994). In this study, we demonstrate 
that inhibitors that block the proteasome inhibit TNFa- 
induced cell surface expression of E-selectin, VCAM-1, 
and ICAM- in endothelial cells. These inhibitors exhibit 
profound functional effects by blocking static adherence 
of leukocytes, as well as attachment and transendothelial 
migration under defined flow conditions. We present bio- 
chemical and functional evidence that the mechanism of 
inhibition occurs at the level of NF-KB activation. These 
findings are consistent with the concept that the NF-KBI 
h&a system may play a pivotal role in regulating leukocyte 
adhesion, and support the idea that rational manipulation 
of the level of specific transcription factors may regulate 
sets of genes controlling complex cellular events, such as 
those involved in endothelial pathophysiologic responses 
in the vasculature. 
Results 
Proteasomel Inhibitors Block TNFa-Induced 
Expression of Cell Surface Adhesion Molecules 
To obtain evidence for involvement of the cellular protea- 
some in TNFa-induced expression of leukocyte adhesion 
molecules, the effects of a panel of proteasome inhibitors 
on surface expression of E-selectin were examined. The 
peptide aldehydes N-acetyl-leucinyl-leucinyl-norleucinal-H 
or Calpain inhibitor I (ALLN), N-carbobenzoxyl-leucinyl- 
leucinyl-norvalinal (MG115), and carbobenzoxyl-leucinyl- 
leucinyl-IeucinalH (MG132) have been shown to inhibit 
the proteolytic activity of the 20s and 26s proteasomal 
complex (Rock et al., 1994). These three inhibitors also 
affect lysosomal proteases, including cathepsin Band cal- 
pain, with similar potency to a structurally related com- 
pound, N-acetyl-leucinyl-leucinyl-methional or Calpain in- 
hibitor II (ALLM), a much weaker inhibitor of the proteasome 
(Rock et al., 1994). Whereas all four compounds have 
similar inhibitory activity against cathepsin Band calpain, 
their distinct inhibitory properties towards the proteasome 
makes them extremely useful reagents to distinguish be- 
tween cellular pathways involving the proteasome or 
cathepsin/calpain-mediated protein degradation or pro- 
cessing. 
Primary cultures of human umbilical vein endothelial 
cells (HUVECs) in microtiter plates were pretreated for 
1 hr with the indicated concentrations of ALLM, ALLN, 
MG132, and MG115, then challenged with TNFa for 4 hr 
in the continued presence of the inhibitors (Figure 1A). 
Cell surface expression of E-selectin, as measured byfluo- 
rescence immunoassay, was essentially absent in unacti- 
vated HUVECs, and dramatically increased in response 
to TNFa. Control levels were unaffected by ALLM (Figure 
1 A), ALLN, MG115, and MG132 (data not shown). Cyto- 
kine-induced expression of E-selectin was profoundly in- 
hibited in a dose-dependent manner by ALLN, MG115, 
and MG132, agents with known inhibitory activity against 
the proteasome. In contrast, ALLM failed to inhibit E-selectin 
expression in response to TNFa. The inhibitors MG132 
and ALLM (Figure lB), and MG115 and ALLN (data not 
shown), had no effect on surface levels of p96, a constitu- 
tively expressed endothelial surface molecule that is not 
regulated by TNFa (Bevilacqua et al., 1969). P96 is now 
known to be endoglin (M. Frosch, B. Seed, and T. C., 
unpublished data), a transforming growth factor j&binding 
protein (Gougos and Letarte, 1990; Cheifetz et al., 1992; 
Bellon et al., 1993). 
The proteasomal inhibitors exhibited similar effects on 
TNFa induction of VCAM-1 and ICAM- surface expres- 
sion (Figures 1 C and 1 D). In these experiments, HUVECs 
were pretreated with inhibitors as in Figure lA, but chal- 
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Figure 1. Inhibition of TNFa-Induced Cell Surface Expression of Leukocyte Adhesion f,iolecules by Proteasomal Inhibitors 
HUVECs in microtiter plates were exposed to indicated concentrations of inhibitors for 1 hr, prior to the addition of 100 U/ml TNFa. Fluorea 
immunoassays for E-selectin and p96 were performed at 4 hr ([A] and [B]), and VCAM-1 and ICAM- at 12 hr ([Cl and [D]). Data are prese 
as mean f SD, and are representative of three separate experiments. 
lenged with TNFa for 12 hr, where maximal surface ex- 
pression of these molecules occurs. MG132 completely 
blocked cytokine-induced VCAM-1 and ICAM- expres- 
sion. During the time course of these experiments, basal 
ICAM- expression was not affected by proteasomal inhib- 
itors. Similar results were observed with ALLN and MG115 
(data not shown), but these were less effective than 
MG132. Again, the structural analog ALLM had no inhibi- 
tory activity. These findings establish that the proteasomal 
inhibitors decrease total expression of three leukocyte ad- 
hesion molecules. 
To examine surface expression of these adhesion mole- 
cules on the entire population of HUVECs, flow cytometric 
analysis was performed on cells exposed to TNFa in 
absence and presence of 20 PM MG132. As showr 
Figure 2, the majority of HUVECs were positive 
E-selectin and VCAM-1 after 6 hr of TNFa treatment. S 
larly, ICAM- surface expression was significantly I 
vated. In contrast, MG132 treatment prior to TNFa sig 
cantly reduced both the proportion of positive cells 
the mean fluorescence intensity of monoclonal antiboc 
(MAbs) that recognize E-selectin, VCAM-1 and ICAl 
In general, MG132 reduced surface expression to ne 
that seen for control unactivated endothelial cells. MG 
did not alter adhesion molecule expression on control 
dia-treated HUVECs. As a further control, the surface 
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Figure 2. Endothelial Expression of E-selectin, VCAM-1, ICAM-1, 
and psS 
Endothelial cells pretreated with control media, or TNFa (166 U/ml, 
6 hr) without or with pretreatment with 26 uM MG132 for 1 hr were 
incubated with MAbs H4/18, El/6, Hu5/3, and El/l to assess the sur- 
face expression of E-selectin, VCAM-1, ICAM-1, and ~96, respectively, 
using indirect immunofluorescence flow cytometric analysis. The fluo- 
rescein-isothiocyanate intensity of endothelial cells stained with an 
isotype-matched nonbinding control (Kl6/6) IgG is indicated by a dot- 
ted line. Data presented are representative of three separate experi- 
ments. 
pression of p96 was not altered by MG132. These findings 
establish that proteasomal inhibitors decrease induced ex- 
pression of all three leukocyte adhesion molecules in the 
entire population of endothelial cells. 
Two conclusions can be made from these observations: 
first, the antiproteasomal agents block expression of the 
leukocyte adhesion molecules, as measured by both cell 
surface fluorescent immunoassay and flow cytometric 
analysis; and second, there is a direct correlation between 
the ability of the compounds tested to inhibit the proteolytic 
activity of the proteasome complex (Rock et al., 1994) 
and the ability of the inhibitors to block TNFa-induced 
expression of adhesion molecules. From this associa- 
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Figure 3. Effects of MG132 on HUVECs Are Reversible and Inhibition 
Is Time Dependent 
(A) Reversibility of proteasomal inhibition and TNFa-induced 
concentrations of MG132 for 1 hr. washed twice in Hanks’ balanced 
salt solution, and incubated in complete medium for 1 hr. Fresh ma 
dium with orwithout 166 U/ml TNFa was added, and fluorescent immu- 
noassay for E-selectin performed at 4 hr. 
(B) Effects of time of addition of MG132 on TNFa-induced E-selectin 
expression. MG132 (20 uh4) was added at the indicated times relative 
to addition of 100 U/ml TNFa. Fluorescent immunoassay for E-selectin 
was performed after 4 hr of exposure to TNFa. 
tion, one can infer that these inhibitory effects on TNFa 
induction of adhesion molecule expression are mediated 
through the proteasome. 
Effects of Proteasomal Inhibition on E-Selectin 
Expression Are Reversible and Time Dependent 
To investigate whether the effects observed on TNFa- 
induced adhesion molecule expression in endothelial cells 
were reversible, HUVECs were treated with various con- 
centrations of MG132 for 1 hr, rinsed, and allowed to re- 
cover for 1 hr before the addition of TNFa for 4 hr (Figure 
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Figure 4. MG132, but Not ALLM, Inhibits TNFa-Induced Adherence 
of Neutrophils Under Static Conditions 
HlJVECs in microtiter plates were pretreated with the indicated con- 
centrations of ALLM or MG132, or DMSO (0.05%) for 1 hr prior to 
addition of TNFa (166 U/ml) for 6 hr. Adherence of fluorescent-labeled 
peripheral blood neutrophils was determined as described in Experi- 
mental Procedures. 
3A). In cells allDWed to recover for 1 hr after inhibitor re- 
moval, TNFa-induced E-selectin expression was compa- 
rable with that seen in untreated cells at the concentration6 
tested (see Figure 1A). Thus, HUVECs fully recover their 
ability to respond to TNFa within 1 hr, indicating that the 
effects of MG132 are reversible. Similar results were ob- 
served in lymphoid cells, where the effect of proteasomal 
inhibitors on total protein turnover was reversible (Rock 
et al., 1994). The reversibility and lack of inhibition of p96 
surface expression indicate that proteasomal inhibition is 
not toxic to the cells under the conditions employed. 
To determine whether pretreatment with proteasomal 
inhibitor6 was necessary to block the effects of TNFa, the 
time of exposure to inhibitor was evaluated. MG132 was 
added to HUVECs at the indicated times before addition of 
TNFa for 4 hr, simultaneous with TNFa, or at the indicated 
times after addition of TNFa (Figure 38). To inhibit TNFa- 
induced E-selectin expression, HUVECs must be exposed 
to MG132 either before or simultaneous with the addition 
of TNFa (Figure 38). Thus, inhibition of the proteasome 
function interferes with early signaling events in response 
to TNFa. 
Proteasomal Inhibitors Block TNFa-Induced 
Leukocyte Adherence, Rolling, 
and Transmigratlon 
The localized adhesion of leukocytes to postcapillary and 
collecting venular endothelium occurs under flow condi- 
tions in vivo and is an essential process during the inflam- 
matory response. Adhesion of peripheral blood neutro- 
phils and lymphocytes to unstimulated endothelial cells is 
low. Cytokine activation of endothelium normally results 
in a surface that is hyperadhesive for nearly all classes 
of peripheral blood IeUkoCyteS. The functional coru 
quences of blocking endothelial adhesion molecule E 
pression by proteasomal inhibitors were evaluated by E 
amining adhesion of leukocytes to endothelium, both uric 
static conditions and under conditions of defined flow. A 
herence of peripheral blood neutrophils to HUVECs uric 
static conditions was enhanced by approximately 25-fc 
in response to 6 hr exposure to TNFa (Figure 4). Pretre, 
ment of HUVECs with MG132 greatly reduced the level 
TNFa-enhanced neutrophil adherence, to less than 5-f< 
when compared with non-TNF-treated HUVECs. Simi 
results were obtained with U937 cells, a monocytic c 
line, where the optimal concentration of MG132 1 
blocking adherence under static conditions was 20 t 
(data not shown). 
To examine the effects of proteasomal inhibition ir 
system that mimics more closely conditions of flow in 1 
microcirculation, the interactions between peripheral bk 
neutrophils and lymphocytes and TNFa-activated endot! 
lium were examined under laminarflow(l.8 dynes/cm2, e 
mated wall shear stress). By videomicroscopy, large nr, 
hers of neutrophils attached, became firmly arrested, 6 
transmigrated across TNFa-activated HUVEC rnoi 
layers, whereas few, if any, neutrophils attached to con 
unactivated endothelial cells (Figure 5, first column, cc 
pare A with B). At higher magnification, many stably 
rested neutrophils flattened and spread on the apical s 
face, moved to intercellular borders, and migra 
beneath the activated endothelium. Transmigrated cc 
are identified by arrows in Figure 5, first column, B and 
The current findings are consistent with previous repc 
(Smith et al., 1989). Pretreatment with MG132 prior 
TNFa addition signficantly reduced neutrophil adhes 
(45% f 7% inhibition) and inhibited - 90% of neutrol 
transmigration (Table 1). Only a small amount of the re! 
ual neutrophil adhesion in the presence of MG132 Y 
blocked by an E-selectin MAb (data not shown). The id 
tity of the molecules mediating residual neutrophil ad 
sion are at present unclear. 
Although neutrophil adhesion was reduced significan 
MG132 caused profound inhibition of transmigration. tJ 
closer inspection after several minutes of flow, mi 
spread neutrophils were observed to project pseudopc 
into the intercellular junctions, but were unable to p6 
trate fully between adjacent endothelial cells in orde 
migrate beneath the monolayers (Figure 5, second 
umn). For example, a neutrophil arrested on the ap 
endothelial surface ha6 spread (Figure 5A, second 
umn, arrow) and then projected pseudopods into the in 
cellular borders between endothelial cells (Figure 58, s 
ond column, pseudopods identified by small arro\ 
Failing to penetrate fully between the endothelial ji 
tions, this neutrophil migrated to a different region on 
same endothelial cell (Figure 5C, second column) ant 
peated the process of extending pseudopods into the 
dothelial borders (Figures 5D and 5E, second colu 
arrows identify pseudopods). Ultimately, this neutro 
failed to migrate beneath the endothelial monolayer 
seconds later was released from the apical surface (Fit 
5F, second column) and was removed by flow. Ret 
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Table 1. MG132 Blocks Leukocyte Adhesion and Transmigration Across TNFa-Activated HUVEC Monolayers under Flow at 1.8 dynes/cm2 
Neutrophils Lymphocytes 
Treatments Adhesion’ Transmigrationb Adhesion’ Transmiaratior? 
Experiment 1 
Media 2*2 Ok0 1+1 o*o 
Media + 132 2*2 o*o ND ND 
8 hr TNFa + ALLM 78 ct 4 38 f 8 20 f 10 2*2 
8 hr TNFa + MG132 43 f 9 5*4 If1 o*o 
Experiment 2 
Media If1 o*o If2 o*o 
Media + 132 2*1 o*o I*2 o*o 
8 hr TNFa + ALLM 70 * 10 31 * 10 12 f 4 3*1 
6 hr TNFa MG132 39 f 13 4i2 I*2 0*1 
Leukocyte adhesion and transmigration were performed as described in Experimental Procedures. Data are mean f SD. 
* Adherent leukocytes per high powered field (40 x objective). 
b Indicates transmigrated leukocytes per high powered (40 x objective). 
Figure 5. Neutrophil Rotling. Arrest, Spreading, 
and Transmigration Across TNFaActivated En- 
dothelium Under Laminar flow Is Inhibited by 
MG132 
(Column I) Various frames of video tape re- 
cordings of neutrophil adhesion under flow 
were digitized and photographed. Neutrophils 
were perfused across endothelial monolayers, 
which had been treated with control media (a), 
or 100 U/ml TNFa for 6 hr without (b) or with 
(c) pretreatment with 20 uM MG132 for 1 hr. 
Arrows indicate spread/transmigrated neutro- 
phils. 
(Column II) Sequential video frames depicting 
neutrophil arrest and spreading were digitized. 
The appropriate areas of interest from each 
digitized video frame were combined using 
commercial software to create the composite 
image (a-f). This composite image shows the 
various stages that occur between neutrophils 
and TNFa-activated HUVECs that have been 
pretreated with 20 pM MG132. (a) Arrow indi- 
cates neutrophil, which has arrested and is be- 
ginning to spread. (b) Same neutrophil (arrow) 
has projected pseudopods (small arrows) into 
the border between two endothelial cells. (c) 
Neutrophil (arrow) failed to migrate, moved to 
another area between two endothelial cells, 
and repeated the pseudopod extension (d and 
e, small arrows). (f) Neutrophil (arrow) retracts 
pseudopods, and moves to another area of the 
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studies indicate that both adhesion molecules, including 
plateleffendothelial cell adhesion molecule-l (PECAM-1, 
CD-31) (Muller et al., 1993) and ICAM- (Smith et al., 
1989), and endothelialderived chemoattractant(s), includ- 
ing platelet-activating factor (Kuijpers et al., 1992) and IL-8 
(Huber et al., 1991), are necessary for efficient neutrophil 
transmigration across cytokine-activated endothelium. 
The inability of neutrophils to transmigrate was not due 
to altered expression of PECAM-1 on HUVEC, as as- 
sessed by immunofluorescence microscopy (data not 
shown). Furthermore, although MG132 treatment prior to 
TNFa activation did reduce IL-8 production and secretion 
into culture supernatant, the differences were not signifi- 
cant (p = 0.058). Thus, inhibition of other steps in the 
migration pathway, including ICAM- expression, must be 
responsible for the decreased ability of the adherent neu- 
trophils to migrate across endothelial monolayers under 
conditions of proteasomal inhibition. 
Similar experiments with peripheral blood lymphocytes 
revealed that these cells also stably arrested, rolled, and 
transmigrated across TNFa-activated HUVEC, albeit in 
smaller numbers than neutrophils (Table 1). The inhibitory 
effects of MG132 were more dramatic for peripheral blood 
lymphocytes. Few freely flowing lymphocytes were able 
to attach to treated endothelial monolayers under flow, 
and thus, adhesion was reduced by>90% and transendo- 
thelial migration was absent. This result is consistent with 
recent findings that lymphocytes and neutrophils utilize 
distinct receptor-ligand pairs in the initial rolling phase of 
adhesion (Luscinskas et al., 1995; reviewed by Carlos and 
Harlan, 1994). 
Effects of Proteaeomal Inhibition on Induction 
of mRNA by TNFa 
Activation of E-selectin, VCAM-1, and ICAM- gene ex- 
pression is known to occur at the level of transcription 
(Whelan et al., 1991; Neish et al., 1992; Wertheimer et al., 
1992). To examine whether inhibition of the proteasome 
blocked TNFa induction of steady-state transcript levels 
for E-selectin, VCAM-1, and ICAM-1, Northern blot analy- 
sis was performed (Figure 8A). HUVECs were incubated 
with or without MG132 for 1 hr, and stimulated with TNFa 
for 3 hr. In unstimulated HUVECs, endogenous message 
levels for E-selectin and VCAM are undetectable, and 
ICAM- is basally expressed at a low level (Figure 8A, 
lane 1). MG132 had no effects on basal levels of these 
transcripts (Figure 8A, lane 2). In the absence of inhibitor, 
3 hr of TNFa treatment strongly induced message levels 
of all three molecules (Figure 8A, lane 3). In the presence 
of MG132, E-selectin transcript induction by TNFa was 
almost completely prevented, whereas transcript for 
VCAM-1 was totally blocked and ICAM levels remained 
at baseline (Figure 8A, lane 4). These results indicate that 
proteasomal inhibition may affect transcription of these 
genes. In contrast, MG132 pretreatment resulted in induc- 
tion of IL-8 message (Figure 8A, lane 2), and TNFa- 
induced transcript levels for IL-8 were not inhibited by pre- 
treatment with MG132 (lanes 3 and 4). These results are 
consistent with the lack of a significant effect of MG132 
on IL-8 release into the media of TNFa-treated HUVECs 
(data not shown). lL-8gene transcription has recently bc 
shown to be under the cooperative control of ClEBPp z 
NF-KB, possibly through ~85 homodimers rather than t 
erodimeric p5O/p85 (Kunsch and Rosen, 1993; Stein 5 
Baldwin, 1993). Perhaps the strong cooperativity betwt 
this combination of transcription factors makes IL-8 tr 
scription less sensitive to effects of lower levels of nucll 
NF-KB, which are found in MG132-treated cells. No con 
nations of TNFa and MG132 affected the constitutive m 
sage for GAPDH, indicating that the levels of a const 
tively expressed gene were not affected by proteasol 
inhibitors (Figure 8A). 
Proteaeomal lnhibltore Reduce TNFa Activation 
of NF-KB in HUVECs 
The E-selectin, VCAM-1, and ICAM- promoters con 
well-characterized NF-KB binding elements necessar) 
transcriptional activation (Whelan et al., 1991; Neisl 
al., 1995; Voraberger et al., 1991). Earlier studies h 
shown that TNFa induces rapid nuclear localization of 
NF-KB subunits p50 and p85 in HUVECs (Read et 
1994). Translocation of p5O/p85 in HUVECs is accorr 
nied by degradation of lKBa, which occurs by 15 r 
To examine the effects of proteasomal inhibitors on II 
degradation, HUVECs were incubated with or without 
inhibitors for 1 hr prior to TNFa treatment for 15 min. 
level of lKBa was determined in cytosolic extracts by W 
ern blot analysis using an IKBa-specific antisera (Fit 
8B). Both MG115 and MG132 markedly inhibited the I 
of lKBa observed in response to TNFa (Figure 8B, c 
pare lanes 1 and 8 with lanes 12 and 13). In contr 
ALLN had a smaller effect on preventing IKBa degrada 
(Figure 8B, lanes 8 and 9), and ALLM did not pre! 
degradation at all (lanes 10 and 11). For comparison, c 
solic levels of p50 and p85 remained constant in respo 
to TNFa and were not changed by exposure to the inl 
tors (Figure 8B). Cytosolic levels of ~105 were not affec 
by TNFa or MG132, consistent with the long half-lif 
~105 when compared with l&a (Donald et al., 1995). 
proteasomal inhibitors appeared to stabilize the phosp 
ylated form of Ma, which was detectable only in extr, 
from TNFa-treated cells in the presence of the inhibi 
(note the appearance of a doublet band, Figure 8B, la 
8, 9, 12, and 13). Recent studies have shown that I 
phosphorylation is insufficient to cause dissociation 1 
~85, and that subsequent degradation of IKBa is ne 
sary for nuclear translocation of NF-KB (Traenckner e 
1994; Finco et al., 1994). Our results suggest that the 
teasome is involved in TNFa-induced degradation of I 
in HUVECs, and lKBa is phosphorylated in HUVECs I 
to degradation. 
A time course of TNFa treatment in the present 
ALLM or MG132 was performed to examine the apt 
ante of nuclear p50 and p85 (Figure 8C). In the press 
of ALLM, TNFa induces nuclear translocation of p50 
~85, which are maintained at a high level over time (Fil 
8C, lanes l-6), similar to what has been observe 
HUVECs treated with TNFa alone (Read et al., 1Z 
However, in the presence of MG132, much less p50 
p65 are translocated to the nucleus at 15 min, and tl 
lmmunfty 
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Figure 6. MG132 Blocks the Increase in Steady-State Transcripts Induced by TNFa and Inhibits TNFa-Induced Degradation of IxBa and Activation 
of NF-KB in HUVECs 
(A) HUVECs were pretreated with 50 pM MG132 for 1 hr prior to the addition of TNFa (100 U/ml) for 3 hr. Total RNA was isolated and Northern 
blots prepared as described in Experimental Procedures. Transcript sizes are indicated on the right. 
(B-D) HUVECs were pretreated with the indicated concentrations of inhibitors for 1 hr and exposed to TNFa (100 U/ml) for 15 min (B) or for the 
indicated times (C). Cytosolic and nuclear fractions were analyzed for IxBa, ~65, and p105/p50 by Western blot (B and C). (D) Nuclear extracts 
from cells treated as described in (B) and exposed to TNFa for 30 min were analyzed for NF-KB DNA binding activity by EMSA using E-selectin 
PDI as a probe. 
levels are not maintained, consistent with the lack of deg- 
radation of cytoplasmic fKBa (Figure 6C, lanes 7-12). 
Results of the Western blots were supported by data ob 
tained from electrophoretic mobility shift assays (EMSA) 
(Figure 6D), using the well-defined E-selectin PDI and 
PDIII NF-KB sites as probes. Treatment with MG132 prior 
to TNFa resulted in decreased PDI DNA binding activity 
from HUVEC nuclear extracts when compared with pre- 
treatment with ALLM (Figure 6D, lanes 3 and 4). By su- 
pershift analyses, the composition of these protein-DNA 
complexes did not change in extracts from cells treated 
with TNFa alone, ALLM with TNFa, or MG132 with TNFa 
(data not shown). To quantitate the effects of MG132 on 
NF-KB binding, TNFa-induced DNA binding activity to 
E-selectin PDI and PDIII was analyzed by phosphoimage 
analysis and normalized to binding to an oligonucleotide 
containing a consensus YYl binding site (Shi et al., 1991). 
Levels of YYl protein and DNA binding in HUVECs are 
not affected by TNFa (M. Frosch and T. C., unpublished 
data). Comparison of quantitated binding to both PDI and 
PDIII shows that the degree of inhibtion by MG132 is 
greater than 50% (Table 2). Thus, although the proteaso- 
mal inhibitor MG132 does not completely block nuclear 
translocation of p5O/p66 in HUVECs, the amount allowed 
into the nucleus is reduced. These diminished levels of 
NF-KB may not be sufficient to induce transcription of the 
NF-KB-dependent cell adhesion molecule genes. 
TNFa-Induced Activation of NF-K&Dependent 
Promoters Is blocked by MG132 
To correlate the absence of adhesion molecule transcript 
and surface expression with diminished levels of nuclear 
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Table 2. Effects of Proteasomal Inhibition on NF-KB DNA Binding 
Probe PDI PDIII WI PDINYI PDlll/YYl 
Experiment 1 
ALLM 
(P.I. unitslpl extract) 
MG132 
(P.I. units/p1 extract) 
Percent Inhibition by MG132 
ALLM 
(P.I. units/u1 extract) 
MG132 
(P.I. unitsArI extract) 
Percent inhibition by MG132 
128 f 18 69 zt 16 1200 f 85 10.7 5.8 
53 f 9 31.5 f IO 1430 * 112 3.7 2.2 
65.4% 62.1% 
248 f 21 155 f 14 2237 f 112 11.1 6.9 
104 f 8 84i4 1919 f 288 5.4 3.3 
51.4% 52.2% 
Data are mean f SD from triplicate phosphoimage analysis. 
MG132 inhibits TNFa-induced NF-KB DNA binding to E-selectin PDI and PDIII. Radiolabeled oligonucleotides (100,000 cpm) containing the 
or PDIII elements of the E-selectin promoter, or an oligonucleotide containing a consensus WI binding site were incubated with nuclear extr 
from TNFa-treated HUVECs pretreated with 20 uM ALLM or MGl32 for 1 hr. Binding reactions were analyzed by EMSA as in Figure 6D, 
bound DNAs quantitated using a phosphoimager. Binding was analyzed relative to binding to an oligonucleotide containing a consensus 
site, to normalize the effective extract concentrations. 
NF-KB, we tested drug effects on cytokine-inducible re- 
porter genes. In these experiments, reporter constructs 
bearing NF-KB site8 from VCAM-1 (both sites, Neish et al., 
1995) and E-selectin (three copies of PDI, Whitley et al., 
1994) were subcloned upstream of a constitutively active 
viral (SV-40) promoter and introduced into bovine aortic 
endothelial cells (BAECs). Transfected cells were then 
challenged with TNFa with or without 1 hr pretreatment 
with the inhibitory agents. As shown in Figure 7, a CAT 
reporter gene under control of the viral promoter exhibited 
a constitutive level of CAT activity that was not inducible 
with TNFa. This level of expression was not significantly 
affected by 2.5 or 5 PM ALLM or MG-132. In contrast, 
the same plasmids bearing NF-KB sites from VCAM-1 or 
E-selectin were inducible by TNFa. Strikingly, the TNFa 
induced activity of both was unaffected by 5 uM ALLM, 
but was totally abolished by pretreatment with 2.5 or 5 PM 
MG-132. Note that the level of activity of the viral reporter 
lacking the NF-KB sites was not significantly altered by 
exposure to either drug, demonstrating that these agents 
do not nonspecifically interfere with basal transcription. 
Reporter constructs driven by the intact core promoter8 
of VCAM-1 and E-selectin were equally susceptible to inhi- 
bition of cytokine induction (data not shown). From these 
data, we concludethat the proteasomal inhibitor, MG-132, 
0 
Mod* ALLM --Yc132- Mod,. &LLM -YG132- Modlo ALLM --MG132--  
5PM 2.5pM SPY SLIM 2.5pY SflY 5pM 2SCM 5UM 
sv-40 VCAM NF-KB E-selectin 
NF-uB 
can abolish NF-rcB-mediated TNFa inducibilty of 
VCAM-1 and E-selectin promoters. These studies con1 
the functional significance of the decreased levels of 
clear NF-KB seen by Western blotting (see Figures 6B i 
6C) and gel shift analysis (see Figure 6D; Table 2) 
are consistent with the dramatic fall in cytokine-indu 
transcript levels seen by Northern blot analysis of F 
from inhibitor-treated endothelial cells (see Figure 61 
Discussion 
The proteasome is involved in both degradation of pra 
substrates, and in the limited proteolysis and proces 
that occurs during posttranslational modification of bit 
ically active proteins (reviewed by Ciechanover, 19 
Our findings using a panel of peptide aldehydes with di 
ential inhibitory capabilities against the proteasome c 
onstrate that proteolytic activity of the proteasome i! 
quired for TNFa induction of the leukocyte adhe 
molecules, E-selectin, VCAM-1, and ICAM-1. Effectso 
proteasomal inhibitor, MG132, on endothelial cells \ 
reversible, and inhibitor must be added prior to or sim 
neous with cytokine addition to be effective. Cytol 
induced transcript levels were almost abolished, ind 
ing interference with early signaling events. Biocher 
Figure 7. TNFa-Induced Activation of N 
Dependent Promoters Is Prevented by M 
BAECs were transfected with 10 ug of S 
CAT, VCAM-NF-KB, or E-selectin NF-KI 
moterlreporter constructs. Following 1 
fection. cells were pretreated with the ind 
concentrations of ALLM or MGI 32 for 1 hr 
media with or without TNFa (200 U/ml) fo 
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studies revealed that TNFa-induced degradation of h&a 
was blocked, and nuclear accumulation of NF-KB was re- 
duced. TNFa inducibilityof E-selectin and VCAM-1 NF-KB- 
dependent promoter-reporter constructs was abolished. 
Together, these results suggest that the decreased level 
of nuclear NF-KB that occurs in MGlSP-treated endothelial 
cells is insufficient to induce transcription of these NF-KB- 
dependent genes. The consequence of inhibiting expres- 
sion of these leukocyte adhesion molecules was a dra- 
matic inability of the endothelial cells to support leukocyte 
adhesion and transmigration. 
These studies contribute to the list of physiological func- 
tions of the ubiquitin-proteasome proteolytic pathway (re- 
viewed by Ciechanover, 1994; Goldberg and Rock, 1992; 
Peters, 1994). The degree of inhibition of induced leuko- 
cyte adhesion molecule expression by the peptide alde- 
hydes correlated with the rank order of potency of these 
drugs to inhibit the proteolytic activity of the proteasome 
(Rock et al., 1994). Thiscorrelation suggests that induction 
of leukocyte adhesion molecules in endothelial cells oc- 
curs by the same inhibitor sensitive step. These results 
are similar to recent observations which demonstrated that 
the proteasome is involved in the degradation of long-lived 
proteins and is required for class I MHC antigen processing 
(Rock et al., 1994), as well as transcription factor activation 
(Palombella et al., 1994). The current study suggests the 
importance of the endothelial proteasome in the signal 
transduction events involved in adhesion molecule ex- 
pression. 
Interestingly, concentrations of MG132 that effectively 
blocked surface expression of E-selectin, VCAM-1, and 
ICAM-1, and lKBa degradation only partially prevented 
nuclear translocation of ~50 and ~65 in response to TNFa. 
Recent identification and cloning of another inhibitor of 
NF-KB, IKBP, may provide further insight into these find- 
ings (Thompson et al., 1995). lrcBa and l~Bf3 display dis- 
tinct responses to activators of NF-KB. In contrast with 
h&a, which is resynthesized following its degradation, 
IKBP does not reappear under similar circumstances. The 
failure of l~Bf3 to be resynthesized suggests that unlike 
lkBa, IKBP may not be up-regulated by NF-KB (reviewed 
by Thanos and Maniatis, 1995). These new findings, cou- 
pled with results of the current study, suggest that NF-KB 
activation in endothelial cells may be under control of an 
additional pathway, perhaps involving IKBP. 
The differences between the profound effects of MG132 
on leukocyte adhesion molecule expression, and the par- 
tial inhibition of nuclear translocation of NF-KB, raises the 
possibility that signaling pathways in addition to NF-KB 
are being affected by proteasomal inhibitors. However, 
TNFa-induced activation of reporter constructs with NF- 
KB sites was abolished by pretreatment with MG132, while 
MG132 had no effect on the activity of a reporter lacking 
NF-KB sites. This apparent discrepancy between the 
partial inhibition of NF-KB activation and the complete 
blocking of adhesion molecule expression and reporter 
gene induction may reflect subtle control processes regu- 
lating expression of KB-dependent genes. Activation of 
NF-KB may be more complex and under additional levels 
of control besides nuclear translocation and DNA binding. 
A recent study has provided evidence that p65 is phos- 
phorylated in response to TNFa in HeLa cells, and that 
DNA binding of ~65 is phosphorylation dependent (Nau- 
mann and Scheidereit, 1994). Phosphorylation may have 
effects on other properties of ~65, such as dimerization 
efficiency and transactivating potential. Alternatively, re- 
sults of the current study may suggest that a threshold 
level of active NF-KB is required to induce transcription 
of the E-selectin, VCAM-1 and ICAM- genes. Multiple 
NF-KB sites with potentially different binding affinities exist 
in the transcriptional control regions of these genes. All 
three genes contain an array of binding sites recognized 
by other transcriptional activators. The decreased level of 
activated NF-KB in MGl32-treated cells may result in a 
sharp decrease in transcription, which could lead to the 
results obsenred at the transcript and protein levels. This 
concept of a small change in the concentration of a tran- 
scriptional activator leading to a dramatic change in the 
level of gene expression has been well established (re- 
viewed by Ptashne, 1992). 
Using an in vitro flow chamber, we have established that 
inhibition of three TNFa-inducible endothelial leukocyte 
adhesion molecules markedly diminishes leukocyte arrest 
and transendothelial migration. Several features of our 
analysis of leukocyte interactions with endothelium treated 
with proteasomal inhibitors merit emphasis. First, the most 
dramatic affect was inhibition of peripheral blood lym- 
phocyte initial attachment and rolling, and thus stable 
adhesion under flow. Recent studies have implicated 
P-selectin and other, as yet unidentified molecules, in 
CD4+ T lymphocyte initial attachment and rolling on TNFa- 
activated endothelium under flow in vitro (Luscinskas et 
al., 1995). The current findings suggest these endothelial 
adhesion pathways are totally dependent on the NF-KB 
signaling mechanism. Second, E-selectin has been viewed 
as the major inducible endothelial adhesion molecule for 
neutrophil initial attachment and rolling on activated endo- 
thelium. Yet, despite the marked inhibition of E-selectin ex- 
pression, many freely flowing neutrophils attached and rolled 
on MG132-treated endothelium. These data suggest that 
other inducible molecules, such as the L-selectin ligand 
(Spertini et al., 1991; Norgard-Sumnicht et al., 1993; Lus- 
cinskas et al., 1994) are either less susceptible to protea- 
somal inhibitors or that the signaling mechanisms for tran- 
scription are independent of the NF-KB system. Third, in 
the presence of MG132, most adherent neutrophils failed 
to diapedese across the endothelial monolayer. This may 
be due to the reduced levels of ICAM- expression or to 
a reduction in other factors, such as platelet-activating 
factor or IL-6, which have been implicated in neutrophil 
adhesion and diapedesis (Smith et al., 1969; Kuijpers et 
al., 1992; Huber et al., 1991). Fourth, the inhibition of neu- 
trophil transmigration by MG132 raises the possibility that 
the endothelial proteasome may play a critical role in regu- 
lating leukocyte migration across endothelium and extrav- 
asation. Leukocyte binding may transmit a signal to endo- 
thelial cells that is mediated in part by the proteasome, 
which induces the endothelial cells to change shape and 
open intercellular junctions, thereby facilitating neutrophil 
passage across endothelium. 
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Normal function of the vasculature depends upon a se- 
ries of carefully balanced and interrelated homeostatic 
mechanisms. These processes maintain the fluidity of the 
blood and the patency of vascular channels, while pre- 
venting loss of vascular contents. Pathologic changes can 
result in avariety of nonadaptive changes in the functional 
properties of the vasculature. These changes include al- 
terations in the interactions of circulating cellular and mac- 
romolecular blood elements with the vessel wail. Such 
changes can result in hyperadhesiveness of leukocytes, 
increased cytokine and growth factor production, altered 
permeability of plasma lipoproteins, and alterations in the 
balance between procoagulant and fibrinolytic activities. 
Collectively, these changes have been designated ‘endo- 
thelial dysfunction” and this process plays an important 
role in the onset and progression of vascular disease (re- 
viewed by Gimbrone, 1995). Several strategies have been 
proposed to decrease the physiologic consequences of 
endothelial dysfunction. For the most part, these are selec- 
tive, in that they inhibit specific genes induced in dysfunc- 
tional endothelium (reviewed by Carlos and Harlan, 1994). 
For example, these strategies include blocking leukocyte- 
endothelial interactions with MAbs, soluble protein forms, 
or peptides derived from the adhesion molecules; blocking 
the cellular interactions with specific carbohydrate struc- 
tures derived from the counterreceptors for the selectins; 
or decreasing induction of the adhesion proteins with spe- 
cific antisense oligonucleotides. These strategies have 
been employed in animal models of ischemia/reperfusion 
injury, acute inflammation, and in models of transplant 
rejection. It has been noted that induction of many of the 
genes in dysfunctional endothelium occurs at the tran- 
scriptional level and that these genes share at least one 
regulatory element, a binding site for NF-KB (reviewed by 
Collins et al., 1993). There is evidence that this transcrip- 
tion factor is required for expression of some of these 
genes in endothelial cells. This suggests that general in- 
hibitors of NF-KB activation may decrease the expression 
of a variety of genes associated with endothelial dysfunc- 
tion and provide a broader novel approach to returning 
the endothelium to a quiescent state. Here, we demon- 
strate that treatment of endothelial cells with proteasomal 
inhibitors decreases nuclear accumulation of NF-KB by 
decreasing h&a degradation and is correlated with de- 
creased endothelial expression of three leukocyte adhe- 
sion molecules and decreased leukocyte transmigration. 
Therefore, the protessomal pathway of NF-KB activation 
may represent a critical target for therapeutic intervention 
in the pathologic conditions associated with endothelial 
dysfunction. 
Experimental Procedures 
Cell Culture and Cytoklne Treatment 
HUVECs and BAECs were isolated and maintained in culture using 
previously described procedures (Gimbrone, 1976; Neish et al., 1992). 
For experiments on cytokine induction, cells were exposed lo recombi- 
nant human TNFa (Genentech, San Francisco, California) at a final 
concentration of 100 or 200 U/ml in complete media. ALLN (Calpain 
inhibitor I) and ALLM (Calpain inhibitor II) were purchased from Boeh- 
ringer Mannheim (Indianapolis, Indiana). MG132 and MG115 were 
provided by Myogenics, incorporated (Cambridge, Massachusetts). 
Proteaaomal inhibitors were prepared as 40 mM stock solution 
DMSO and added to complete medium before use. 
For adhesion studies in the flow plate apparatus, HUVEC (past 
1-2) were plated at 60% confluence on fibronectin-coated (2 ps/i 
25 mm circular glass coverslips (number 1 thickness, Thomas SC 
tific, Swedesboro, New Jersey). For surface immunofluoresct 
studies, HUVEC were plated on 0.1% gelatin-coated or fibrone 
coated T-75 flasks (Corning). Experiments were initiated once 
monolayers reached confluence (typically after 46 hr). 
Cell Surface Fluorescent Immunocuscly 
Cell surface binding aeeaye were performed at 4OC on viable HU’ 
monolayers in microtiter plates, using saturating concentration 
MAb supernatants and fluorescent-conjugated F(abqr goat anti-ml 
immunoglobulin G (IgG; Caltag Labs, San Francisco, California). , 
bodies to E-selectin (H4/16), VCAM-1 (E1/6), ICAM- (Hu5/3), clc 
MHC (W6/32), and p96 (El/l) were provided by Dr. M. A. Gimbo 
Jr. (Brigham and Women’s Hospital, Boston). Fluorescent levels \ 
determined using an automated plate reader (Pandex, Baxter He 
care Corporation). 
Leukocyte Isolation 
Human neutrophils and lymphocytes were isolated from antic0 
lated whole blood by centrifugation on Ficoll-Hypaque density g 
ent centrifugation at 15OC (LSM, Organon Teknika, Durham, Ir 
Carolina). The buoyant mononuclear cells were washed once and i 
bated in 150 cm* culture flasks at 37OC for 90 min to allow mono< 
to adhere firmly. Nonadherent lymphocytes (96% purity by Wri 
Giemaa stain) were washed once in RPMI, 10% fetal calf serum 
used in flow studies. Neutrophils were further purified by dextran 
mentation and hypotonic lysis as detailed previously (Luecinsk; 
al., 1969), and were 95% pure by Wright-Giemsa stain. 
Quantitative Static Adheslon Assay 
Adhesion of unsnmulated neutrophils or U937 cells to HUVEC n 
layers was determined as previously described (Westlin and 
brone, 1993). Following exposure to inhibitors, TNFa, or both, c( 
ent HUVEC monolayera in microtiter plates were rinsed and coincul 
with bis-carboxyethyl-carboxyfluoreacein acstoxymethly eater-Id 
neutrophils or U937 cells (1OYwell) for 15 min at 37OC. Nonadh 
cells were removed by centrifugation. The number of adherent 
was quantified by lysing the contents of the wells in 10 mM Tris 
(pH 6.4), 0.1% SDS and fluorescence was determined in a micr 
plate fluorimeter. Percent adherence was calculated aa follows 
percent of adherence = (lysate fluorescent unite/total fluore 
units) x 100. 
Endothellal-Leukocyte Interactlons In a Pamllel Plate 
Flow Chamber 
The parallel plate flow chamber used for leukocyte adhesion I 
defined laminar flow in this study has been described in detail ( 
et al., 1992; Luecinskas et al., 1995). In brief, confluent endol 
monolayers on glass coverelips were incubated with culture r 
containing MG132 or ALLM (20 PM) for 1 hr and then treater 
mediaormediacontainingTNFa(100U/ml; Genentech, lncorpor 
After 6 hr of incubation, HUVEC monolayers were placed in the ( 
ber and then lymphocytes or neutrophils (IO6 cellslml) were I 
through the chamber at 0.65 mUmin. The entire period of perl 
was recorded on videotape. Leukocyte adhesion was determine1 
6-10 min of perfusion by analysis of 12-15 high power (40 x) 
from videotape. Lymphocytes and neutrophils that had migrate 
neath the endothelial monolayer were easily distinguished b) 
flattened and phase dense morphology under a 60 x phase cc 
objective (see Figure 6). In other analyses, selected video frame! 
digitized and printed on aTektronix II SDX digital printer using 1 
Photoshop software. 
Immunofluorescence and Flow Cytometric Assay8 
Indirect immunofluoreacence flow cytometric assays for E-se 
VCAM-I, ICAM- and p96 surface expression on control and 
treated HUVEC were performed as previously reported (Luscins 
al., 1969). The fluorescence of 10’ cells was measured on a FA( 
(Beckon Dickinson) and the histograms are presented aa mean cl 
fluorescence (4 decade log scale) versus relative cell number 
Immunity 
504 
statletks 
The adhesion data was collected using ANOVA and a Student’s two 
sample t test was used to calculate statistical significance (Minitab 
statistical software, release 7, Minitab, Incorporated, State College, 
Pennsylvania). p values < 0.05 were considered significant. 
Northern Analysis 
Total RNA from 107cells was isolated by the guanidine isothiocyanate 
method (Sambrook et al., 1969). RNA was separated by electrophore- 
sis on a 1% agarose formaldehyde gel, transferred to Hybond-N mem- 
brane(Amersham Corporation, Arlington Heights, Illinois) and immobi- 
lized by ultraviolet irradiation with an ultraviolet stratalinker 2400 
(Stratagene, La Jolla, California). Blots were prehybridized for 6 hr 
and hybridized overnight at 42OC with =P-labeled probes (Megaprime 
kit, Amersham Corporation). 
EMSA 
Following experimental treatment of HUVECs, nuclear extracts were 
prepared as described previously (Whitley et al., 1994). Oligonucleo- 
tides were gel purified, annealed, and end-labeled with [a-SP]dATP or 
[a-SZP]dCTP (50 uCi at 3000 Ciimmol. New England Nuclear, Boston, 
Massachusetts) and the Klenow fragment of Escherichia coli DNA 
polymerase I. Binding reactions and electrophoresis were performed 
as described (Whitley et al., 1994). Dried gels were scanned on a 
phosphoimager (Molecular Dynamics) and bound DNA was quanti- 
tated using lmageQuantsoftware(Molecular Dynamics). The following 
oligonucleotides were utilized: E-selectin PDI, S-ggatGCCATTGGG- 
GATTTCCTCTFTACTGGATGT-3’; E-selectin PDIII, B’QagcATCGTG- 
GATAGGACAGGGAAAGTTTTTGGATC-3’; YYl consensus, S’cgct- 
CCGCGGCCATClTGGCGGCTGGT-3: Lower case letters represent 5’ 
labeling overhang. Boldface letters indicate target sites. 
Transfectlons and CAT Assays 
BAECs were transfected with a modified calcium phosphate technique 
(Sambrook et al.. 1969). Cells were transfected with 10 ug of reporter 
plasmid. Designated plates were treated with the indicated concentra- 
tions of MGl32 or ALLN as described above for 1 hr. Following drug 
treatment, the media of appropriate plates were supplemented with 
TNFa (200 U/ml). Cells were harvested 6 hr after TNFa stimulation and 
CAT activity assayed as previously described (Whitley et at., 1994). 
Results are reported as the mean CAT activity of thrse independent 
experiments. 
Western Blots and Antlsera 
Antisera to the Rel proteins p65 (N and C termini), and ~105 were 
provided by N. Rice (National Cancer Institute, Frederick, Maryland; 
Rice and Ernst, 1993) and W. Greene (University of California, San 
Francisco, California; Sun et al., 1993). Antisera to IxBa was pur- 
chased from Santa Cruz Biotechnology, Incorporated (Santa Cruz, 
California). Following experimental treatment of HUVECs, cytosolic 
and nuclear extracts were prepared as described previously (Read et 
al., 1994; Whitley et al., 1994). Extracts were electrophoresed on 6% 
SDS polyacrytamide gels and transferred to nitrocellulose in 25 mM 
Tris, 192 mM glycine, 5% methanol at IOOV for 1 hr. Anti-p65, anti- 
~105, and anti-l&a were used at l:lO,OOO, l:lO,OOO, and l:lOOOdilu- 
tions, respectively. lmmunoreactive proteins were detected according 
to the enhanced chemiluminescent protocol (Amersham Corporation, 
Arlington Heights, Illinois) using l:lO,OOO horseradish peroxidase- 
linked donkey anti-rabbit secondary antiserum. Blots were exposed 
to film for l-5 min. 
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